Safety and activity of PD1 blockade by pidilizumab in combination with rituximab in patients with relapsed follicular lymphoma: a single group, open-label, phase 2 trial
published in: Lancet Oncology Commission
date of publication: 2013-12-11
main subject: phase II clinical trial, patient, follicular lymphoma, rituximab
Cites articles 53
- 2012-10-01
- 2011-06
Date
Title
Article - wd:Q34391446